Woojin B&G, a company specializing in veterinary pharmaceuticals, has signed a product supply contract worth a total of $1.05 million (approximately KRW 1.4 billion) with CP Group, one of the largest livestock companies in Vietnam.
Woojin B&G announced on July 2, 2025, that it will supply three major veterinary therapeutic products, including 'Flojec 400,' to CP Group in Vietnam in the second half of the year.
The company also stated that it is currently in the process of obtaining sales approval from the Vietnamese government for IMMUNIS PED-M, a porcine epidemic diarrhea vaccine it developed and is already supplying in Korea. There are also high expectations for vaccine exports to the Southeast Asian market, including to CP Group.
IMMUNIS PED-M is a product whose preventive efficacy against highly pathogenic PED virus has been proven.
Woojin B&G commented, "CP Group in Vietnam is the largest livestock company in Southeast Asia with a strong foundation of trust in the region. We are not only supplying products but also pursuing a strategy to strengthen our long-term partnership."
Celebrating its 48th anniversary this year, Woojin B&G offers a wide range of animal health solutions, including antibiotics, vaccines, probiotics, and feed additives. The company aims to achieve exports exceeding KRW 10 billion through R&D and global market expansion.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
